Today's relative strength is indicative of buying pressure in a down market. Market sees the sector as bullish and PRGO will do even better due to "more prescriptions at lower cost." Resistance levels ahead. at 27.85 & 28.55 &28.85.
Not if what the FDA is writing means anything.What is the compliance status of Perrigo? It is NOT called out in the EIR as it should be. And where are the approvals from the FDA?And, what is the status of the class action suit? All the business fundamentals aside there are other factors at play here.